Novel treatments

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/353 (2006.01) A61P 9/00 (2006.01) A61P 9/10 (2006.01) A61P 25/06 (2006.01) A61P 25/08 (2006.01)

Patent

CA 2726874

The present invention relates to the treatment of the premonitory symptoms of migraine, to the treatment of aura associated with or without migraine, epilepsy, non-epileptic seizures, stroke or other cardiovascular disorders, to the pre-emptive treatment of aura, migraine, epilepsy, stroke or other cardiovascular disorders, to the treatment of migraine recurrence or aura re-currence,and to tonabersat, co-crystals thereof, and compositions comprising tonabersat for use in said treatments.

L'invention concerne le traitement de symptômes précurseurs de la migraine, le traitement d'une aura associée ou non à la migraine, de l'épilepsie, de crises non épileptiques, d'accidents vasculaires cérébraux ou d'autres troubles cardio-vasculaires, le traitement préventif de l'aura, de la migraine, de l'épilepsie, d'accidents vasculaires cérébraux ou d'autres troubles cardio-vasculaires, le traitement de la récurrence de la migraine ou de la récurrence de l'aura. L'invention concerne également le tonabersat, des co-cristaux de tonabersat, et des compositions comprenant du tonabersat à utiliser dans de tels traitements.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel treatments does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel treatments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel treatments will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2070380

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.